Ryan Zimmerman
Stock Analyst at BTIG
(4.30)
# 336
Out of 4,840 analysts
175
Total ratings
54.73%
Success rate
13.51%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Downgrades: Neutral | n/a | $59.37 | - | 12 | May 27, 2025 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $41.95 | +57.33% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $265.26 | +1.79% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $95.29 | +56.37% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $554.82 | +1.11% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $381.68 | +3.23% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $2.57 | +289.11% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $85.34 | +24.21% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $12.95 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $93.08 | +35.37% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $71.10 | +40.65% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $72.37 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $16.02 | +355.68% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $18.15 | +192.01% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.70 | +326.68% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.81 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.12 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.61 | +148.05% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $2.88 | +108.70% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.66 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $20.75 | +150.66% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.31 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $10.01 | +179.72% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $157.00 | +27.39% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $323.70 | +8.12% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $132.72 | -2.05% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $58.60 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $81.77 | +56.54% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $13.55 | +10.70% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $64.25 | +41.63% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $21.10 | +99.05% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.29 | +892.44% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.29 | - | 3 | Apr 2, 2020 |
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $59.37
Upside: -
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $41.95
Upside: +57.33%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $265.26
Upside: +1.79%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $95.29
Upside: +56.37%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $554.82
Upside: +1.11%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $381.68
Upside: +3.23%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $2.57
Upside: +289.11%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $85.34
Upside: +24.21%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $12.95
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $93.08
Upside: +35.37%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $71.10
Upside: +40.65%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $72.37
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $16.02
Upside: +355.68%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $18.15
Upside: +192.01%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.70
Upside: +326.68%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.81
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.12
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.61
Upside: +148.05%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $2.88
Upside: +108.70%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $7.66
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $20.75
Upside: +150.66%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $11.31
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $10.01
Upside: +179.72%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $157.00
Upside: +27.39%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $323.70
Upside: +8.12%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $132.72
Upside: -2.05%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $58.60
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $81.77
Upside: +56.54%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $13.55
Upside: +10.70%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $64.25
Upside: +41.63%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $21.10
Upside: +99.05%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.29
Upside: +892.44%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $11.29
Upside: -